Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400083327Phase 4Not yet recruiting
Phase 4 trial of midazolam in anxiety disorder (5 arms), sponsored by Dongguan Maternal and Child Health Care Hospital. Primary endpoint: Incidence of anxiety before anesthesia induction. Planned start Apr 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400083327.